Metformin for the treatment of the polycystic ovary syndrome

被引:197
|
作者
Nestler, John E.
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 01期
关键词
D O I
10.1056/NEJMct0707092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 23- year- old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual periods per year and is not interested in becoming pregnant now, but she will be getting married in a year. She has heard that the polycystic ovary syndrome is associated with diabetes and is concerned because both her mother and father have type 2 diabetes. Her body-mass index ( the weight in kilograms divided by the square of the height in meters) is 32, her waist circumference is 38 in. ( 96.5 cm), her serum total testosterone level is elevated at 0.9 ng per milliliter ( 90 ng per deciliter, or 2.9 nmol per liter), her plasma high- density lipoprotein cholesterol level is 35 mg per deciliter ( 0.9 mmol per liter), and her triglyceride level is 190 mg per deciliter ( 2.1 mmol per liter). Her serum glucose level 2 hours after the ingestion of 75 g of dextrose is 138 mg per deciliter ( 7.7 mmol per liter). The physician wonders whether treatment with metformin would be beneficial and refers the patient to an endocrinologist.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [1] Metformin in the treatment of polycystic ovary syndrome
    Beatriz Motta, Dra Alicia
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (21) : 2121 - 2125
  • [2] Metformin for the treatment of polycystic ovary syndrome
    Barbieri, RL
    OBSTETRICS AND GYNECOLOGY, 2003, 101 (04): : 785 - 793
  • [3] Use of metformin in the treatment of polycystic ovary syndrome
    Genazzani, Alessandro D.
    Ricchieri, Federica
    Lanzoni, Chiara
    WOMENS HEALTH, 2010, 6 (04) : 577 - 593
  • [4] Treatment of Metformin on women with polycystic ovary syndrome
    曹晓航
    张俊吉
    施璧
    Rolando Martins
    罗新
    生殖医学杂志, 2009, 18(S2) (S2) : 85 - 89
  • [5] Metformin and Polycystic Ovary Syndrome
    Yousef, Maha
    Omran, Soliman
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2007, 1 (01): : 75 - 80
  • [6] Metformin in polycystic ovary syndrome
    Lord, J
    Wilkin, T
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2004, 16 (06) : 481 - 486
  • [7] Metformin and polycystic ovary syndrome
    De Geyter, Christian
    Emch, Fabienne
    Ahler, Astrid
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2018, 16 (03): : 191 - 194
  • [8] Metformin and the polycystic ovary syndrome
    Nestler, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03): : 1430 - 1430
  • [9] Metformin in polycystic ovary syndrome
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (17): : 1867 - 1868
  • [10] Metformin in polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Economou, Frangiskos
    Palimeri, Sotiria
    Christakou, Charikleia
    WOMEN'S HEALTH AND DISEASE, 2010, 1205 : 192 - 198